Pilot Trial of Preoperative (Neoadjuvant) Letrozole in Combination With Bevacizumab in Postmenopausal Women With Newly Diagnosed Estrogen Receptor–or Progesterone Receptor–Positive Breast Cancer

INTRODUCTION: Tumor content or expression of vascular endothelial growth factor (VEGF) is associated with impaired efficacy of antiestrogen adjuvant therapy. We designed a pilot study to assess the feasibility and short-term efficacy of neoadjuvant letrozole and bevacizumab (anti-VEGF) in postmenopa...

詳細記述

保存先:
書誌詳細
出版年:Clin Breast Cancer
主要な著者: Forero-Torres, Andres, Saleh, Mansoor N., Galleshaw, Janice A., Jones, Cheryl F., Shah, Jatin J., Percent, Ivor J., Nabell, Lisle M., Carpenter, John T., Falkson, Carla I., Krontiras, Helen, Urist, Marshall M., Bland, Kirby I., De Los Santos, Jennifer F., Meredith, Ruby F., Caterinicchia, Valerie, Bernreuter, Wanda K., O'Malley, Janis P., Li, Yufeng, LoBuglio, Albert F.
フォーマット: Artigo
言語:Inglês
出版事項: 2010
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4451110/
https://ncbi.nlm.nih.gov/pubmed/20705559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3816/CBC.2010.n.035
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料